The transfection and expression of IL-1ra gene to the rabbit cornea in situ via cation polymer mediation

Chinese Journal of Ophthalmology

Volumn 42, Issue 8, 2006, Pages 686-693

  Yuan, Jin ^a   Chen, Jia Qi ^b   Zhou, Shi You ^b   Wang, Zhi Chong ^b   Gu, Jian Jun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b NONE

Author keywords

Cornea; Polyethyleneimine; Receptors, interleukin 1; Transfection

Indexed keywords

CATION; COMPLEMENTARY DNA; DNA FRAGMENT; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MESSENGER RNA; PLASMID DNA; POLYETHYLENEIMINE; PROTEIN P63; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CORNEA CELL; CORNEA EPITHELIUM; DNA SEQUENCE; ENDOTHELIUM CELL; ENZYME ANALYSIS; EPITHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC CODE; GENETIC RECOMBINATION; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NONHUMAN; PROTEIN EXPRESSION; RABBIT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; CORNEA; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; PLASMIDS; POLYETHYLENEIMINE; RABBITS; RATS; RATS, WISTAR; TRANSFECTION;

EID: 33749592198     PISSN: 04124081     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Eisenberg SP, Evans RJ, Arend WP, et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature,1990,343: 341-346.
2. Dinarello CA. Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol, 2004,4: 378-385.
3. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. Transplantation, 1997,63: 1501-1507.
4. Yamada J, Dana MR, Sotozono C, et al. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res, 2003,76:161-167.
5. Wolff JA, Malone RW, William P, et al. Direct gene transfer into mouse muscle in vivo. Science, 1990,247:1465-1473.
6. Chinese source. 1996. 547-569.
7. Freeman BD, Buchman TG. Interleukin-1 receptor antagonist as therapy for inflammatory disorders. Expert Opin Biol Ther, 2001, 1: 301-308.
8. Arend WP, Joslin FG, Thompson RC, et al. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J Immunol,1989, 143:1851-1858.
9. Torres PE, De-Vos AF, van-der-Gaag R, et al. Cytokine mRNA expression during experimental corneal allograft rejection. Exp Eye Res, 1996, 63: 453-461.
10. Bragonzi A, Dina G, Villa A, et al. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther, 2000, 7: 1753-1760.
11. Masad I, Matauo T, Yasuda T, et al. Gene transfer with liposome to the intraocular tissues by different mutes of administration. Invest Ophthalmol Vis Sic, 1996,37:1914-1926.
12. Stechschulte SU, Joussen AM, Von Recum HA, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sic, 2001, 42: 1975-1979.
13. Larkin D, Jun AS. Prospects for gene therapy in corneal disease. Eye,2003,17:907-911.
14. Borras T. Recent developments in ocular gene therapy. Exp Eye Res, 2003,76:643-652.